Smithsonian Magazine on MSN
Women are more likely to have irritable bowel syndrome. This newfound gut pain pathway might explain why
Between 25 million and 45 million people in the United States live with irritable bowel syndrome (IBS), a chronic disorder that causes cramps, diarrhea, bloating and other painful symptoms. Around two ...
Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) ...
An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act. The University of Alabama at ...
Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients ...
Scientists discovered that common food emulsifiers consumed by mother mice altered their offspring’s gut microbiome from the ...
News-Medical.Net on MSN
How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson
GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...
Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...
Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the two pivotal Phase 3 randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback